Display options
Share it on

J Med Virol. 2021 May;93(5):2557-2563. doi: 10.1002/jmv.26671. Epub 2020 Dec 01.

COVID-19 in HIV-infected patients: A case series and literature review.

Journal of medical virology

Neeraja Swaminathan, Peter Moussa, Nidhi Mody, Kevin B Lo, Gabriel Patarroyo-Aponte

Affiliations

  1. Albert Einstein Medical Center, Philadelphia, Pennsylvania, USA.

PMID: 33200823 PMCID: PMC7753685 DOI: 10.1002/jmv.26671

Abstract

During the current COVID pandemic, there is growing interest to identify subsets of the population that may be at a higher than average risk of infection. One such group includes people living with HIV.

© 2020 Wiley Periodicals LLC.

Keywords: COVID; HIV; SARS-CoV-2; coronavirus

References

  1. Gervasoni C, Meraviglia P, Riva A, et al. Clinical features and outcomes of HIV patients with coronavirus disease 2019. Clin Infect Dis. 2020:ciaa579. https://doi.org/10.1093/cid/ciaa579 - PubMed
  2. Blanco JL, Ambrosioni J, Garcia F, et al. COVID in patients with HIV: clinical case series. Lancet HIV. 2020;7(5):e314-e316. https://doi.org/10.1016/S2352-3018(20)30111-9 - PubMed
  3. Härter G, Spinner CD, Roider J, et al. COVID in people living with human immunodeficiency virus: a case series of 33 patient. Infection. 2020;48:1-6. https://doi.org/10.1007/s15010-020-01438-z - PubMed
  4. Shiau S, Krause KD, Valera P, Swaminathan S, Halkitis PN. People living with HIV: a syndemic perspective. AIDS Behav. 2020;24:1-6. https://doi.org/10.1007/s10461-020-02871-9 - PubMed
  5. Testing and data: Department of Public Health; n.d. https://www.phila.gov/programs/coronavirus-disease-2019-covid-19/testing-and-data/. Accessed June 23, 2020. - PubMed
  6. Gao Y, Chen Y, Liu M, Shi S, Tian J. Impacts of immunosuppression and immunodeficiency on COVID: a systematic review and meta-analysis. J Infect. 2020;81:e93-e95. https://doi.org/10.1016/j.jinf.2020.05.017 - PubMed
  7. Cao B, Wang Y, Wen D, et al. A trial of lopinavir-ritonavir in adults hospitalized with severe COVID. N Engl J Med. 2020;382(19):1787-1799. https://doi.org/10.1056/NEJMoa2001282 - PubMed
  8. Parang K, El-Sayed NS, Kazeminy AJ, Tiwari RK. Comparative antiviral activity of remdesivir and anti-HIV nucleoside analogs against human coronavirus 229E (HCoV-229E). Molecules. 2020;25(10):E2343. https://doi.org/10.3390/molecules25102343 - PubMed
  9. US Department of Health and Human Services. Interim guidance for COVID and persons with HIV. https://aidsinfo.nih.gov/guidelines/html/8/covid-19-and-persons-with-hiv--interim-guidance-/554/interim-guidance-for-covid-19-and-persons-with-hiv - PubMed
  10. Altuntas Aydin O, Kumbasar Karaosmanoglu H, Kart Yasar K. HIV/SARS-CoV-2 coinfected patients in Istanbul, Turkey. J Med Virol. 2020;92:2288-2290. https://doi.org/10.1002/jmv.25955 - PubMed
  11. Suwanwongse K, Shabarek N. Clinical features and outcome of HIV/SARS-CoV-2 coinfected patients in The Bronx, New York City. J Med Virol. 2020;92:2387-2389. https://doi.org/10.1002/jmv.26077 - PubMed
  12. Karmen-Tuohy S, Carlucci PM, Zervou FN, et al. Outcomes among HIV-positive patients hospitalized with COVID-19. J Acquir Immune Defic Syndr. 2020;85:6-10. https://doi.org/10.1097/QAI.0000000000002423 - PubMed
  13. Shalev N, Scherer M, LaSota ED, et al. Clinical characteristics and outcomes in people living with HIV hospitalized for COVID-19. Clin Infect Dis. 2020:ciaa635. https://doi.org/10.1093/cid/ciaa635 - PubMed
  14. Vizcarra P, Pérez-Elías MJ, Quereda C, et al. Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort. Lancet HIV. 2020;S2352-3018(20):30164-30168. https://doi.org/10.1016/S2352-3018(20)30164-8 - PubMed
  15. Richardson S, Hirsch JS, Narasimhan M, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID in the New York City area. JAMA. 2020;323(20):2052-2059. https://doi.org/10.1001/jama.2020.6775 - PubMed

MeSH terms

Publication Types